MedTrace Logo

An Observational Study on Intermittent Self Catheterisation Discontinuation Factors in Multiple Sclerosis Patients

NCT04132037 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2019-10-18

No results posted yet for this study

Summary

Urinary disorders (UD) are common in Multiple Sclerosis (MS) and can necessitate using Intermittent Self Catheterisation (ISC). It is well experienced by patients, has little impact on daily life and improves quality of life. However, studies are lacking on long-term adherence to this treatment as well as on discontinuation factors. Our main objective is to prospectively assessed factors associated with ISC discontinuation 2 years after having introduced this technique.

Conditions

Interventions

OTHER

data record

At each protocol's visit, clinical and urinary data will be recorded and the answers of the questionnaires will be also reported

Sponsors & Collaborators

  • French Association for Research on Multiple Sclerosis

    collaborator UNKNOWN

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • castel lacanal EVELYNE · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-26
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04132037 on ClinicalTrials.gov